Profile data is unavailable for this security.
About the company
Laekna Inc is an investment holding company mainly engaged in the discovery, development and commercialization of innovative therapies for cancer, liver diseases and obesity. The Company is still in the research and development stage. The Company's pipeline products include Afuresertib (LAE002), LAE001, LAE109, LAE111, LAE112, LAE113, LAE117, LAE118, LAE119, LAE102, LAE103, LAE104, LAE105, LAE106, LAE120, LAE123, and others. The Afuresertib is an adenosine triphosphate (ATP) competitive AKT inhibitor. The LAE001 is an androgen synthesis inhibitor that can inhibit CYP17A1 and CYP11B2 at the same time. The Company mainly conducts business in the Chinese, America, European, Korean, and other markets.
- Revenue in HKD (TTM)0.00
- Net income in HKD-272.08m
- Incorporated2016
- Employees84.00
- LocationLaekna Inc3-2-467, 5 Xingbin Road (Lin Li Center),NINGBO ChinaCHN
- Websitehttps://www.laekna.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clover Biopharmaceuticals Ltd | 58.64m | -1.03bn | 2.86bn | 243.00 | -- | -- | -- | 48.70 | -0.8203 | -0.8203 | 0.0466 | -1.49 | 0.0433 | 0.0547 | 47.89 | 195,458.50 | -76.07 | -75.37 | -- | -188.14 | 62.57 | -- | -1,756.85 | -13,419.00 | 0.2541 | -- | -- | -- | -2.13 | -- | -552.11 | -- | -24.90 | -- |
| Hua Medicine | 419.81m | 1.22bn | 3.21bn | 285.00 | 2.48 | 2.49 | 2.55 | 7.65 | 1.23 | 1.23 | 0.4253 | 1.22 | 0.2411 | 1.76 | 5.71 | 2,498,850.00 | 69.99 | -21.83 | 82.64 | -25.31 | 52.55 | -- | 290.30 | -395.24 | 7.00 | -- | 0.2038 | -- | 234.02 | -- | -18.42 | -- | -17.81 | -- |
| BioDlink International Co Ltd | 1.21bn | 8.22m | 3.25bn | 604.00 | 370.46 | 3.92 | 35.51 | 2.69 | 0.0113 | 0.0113 | 1.67 | 1.07 | 0.7275 | 2.35 | 5.49 | 1,977,613.00 | 0.495 | -11.37 | 0.6586 | -14.89 | 71.10 | 73.14 | 0.6805 | -24.91 | 1.68 | 1.83 | 0.3519 | -- | 40.70 | 89.20 | 192.05 | -- | 27.04 | -- |
| Medtide Inc | -100.00bn | -100.00bn | 3.73bn | 520.00 | -- | 2.24 | -- | -- | -- | -- | -- | 11.73 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 4.48 | -- | 0.0335 | -- | 31.31 | -- | 21.00 | -- | -- | -- |
| Visen Pharmaceuticals | -100.00bn | -100.00bn | 3.80bn | 54.00 | -- | 3.62 | -- | -- | -- | -- | -- | 9.23 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0014 | -- | -- | -- | 26.98 | -- | -- | -- |
| Qyuns Therapeutics Co Ltd | 362.84m | -217.22m | 4.64bn | 337.00 | -- | 17.88 | -- | 12.77 | -0.978 | -0.978 | 1.63 | 1.15 | 0.2903 | 4.05 | 9.14 | 1,070,314.00 | -17.90 | -- | -28.45 | -- | 72.44 | -- | -61.64 | -- | 1.43 | -23.19 | 0.7466 | -- | -- | -- | 33.91 | -- | -- | -- |
| Jacobio Pharmaceuticals Group Co Ltd | 228.07m | -51.70m | 4.72bn | 211.00 | -- | 4.82 | -- | 20.70 | -0.0668 | -0.0668 | 0.2948 | 1.25 | 0.1547 | -- | 7.97 | 887,438.90 | -3.51 | -36.09 | -4.01 | -39.58 | 100.00 | 65.67 | -22.67 | -283.16 | -- | -- | 0.1415 | -- | 145.13 | -- | 56.64 | -- | 29.33 | -- |
| TYK Medicines Inc | 121.19k | -317.21m | 4.86bn | 163.00 | -- | 11.74 | -- | 40,143.25 | -0.8554 | -0.8554 | 0.0003 | 1.09 | 0.0002 | -- | -- | 792.07 | -42.68 | -- | -- | -- | 13.08 | -- | -263,981.30 | -- | -- | -- | 0.3215 | -- | -- | -- | -1.18 | -- | -- | -- |
| Laekna Inc | 0.00 | -272.08m | 5.56bn | 84.00 | -- | 6.29 | -- | -- | -0.7398 | -0.7398 | 0.00 | 1.98 | 0.00 | -- | -- | 0.00 | -27.79 | -- | -34.25 | -- | -- | -- | -- | -- | -- | -- | 0.1383 | -- | -- | -- | 31.05 | -- | -- | -- |
| Edding Genor Group Holdings Ltd | 253.70m | 22.82m | 6.09bn | 17.00 | 67.63 | 1.28 | 175.08 | 24.00 | 0.0450 | 0.0450 | 0.4885 | 2.37 | 0.1724 | -- | 5.21 | 10,571,020.00 | 1.46 | -48.63 | 1.72 | -55.19 | 99.56 | 97.88 | 8.45 | -2,303.07 | -- | -- | 0.0007 | -- | -- | 73.71 | 92.40 | -- | -43.79 | -- |
| MiRXES Holding Co Ltd | -100.00bn | -100.00bn | 6.59bn | 347.00 | -- | 7.40 | -- | -- | -- | -- | -- | 2.99 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.83 | -- | 0.1682 | -- | -16.14 | -- | -33.37 | -- | -- | -- |
| CARsgen Therapeutics Holdings Ltd | 95.19m | -591.11m | 8.21bn | 371.00 | -- | 7.61 | -- | 86.28 | -1.08 | -1.08 | 0.173 | 1.89 | 0.0465 | 5.13 | 7.63 | 203,396.60 | -28.88 | -76.51 | -32.44 | -89.25 | 50.57 | -- | -621.16 | -12,640.86 | 6.40 | -- | 0.0672 | -- | -- | -- | -6.73 | -- | -28.32 | -- |
Data as of Feb 13 2026. Currency figures normalised to Laekna Inc's reporting currency: Hong Kong Dollar HKD
5.08%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Aegon-Industrial Fund Management Co., Ltd.as of 30 Jun 2025 | 13.61m | 3.05% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 4.30m | 0.96% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 1.71m | 0.38% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 1.16m | 0.26% |
| SSgA Funds Management, Inc.as of 08 Jan 2026 | 762.00k | 0.17% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 2025 | 614.50k | 0.14% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 288.00k | 0.07% |
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2025 | 103.50k | 0.02% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 70.00k | 0.02% |
| Truvalue Asset Management Co. Ltd.as of 30 Jun 2025 | 50.50k | 0.01% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
